Fingolimod alters the transcriptome profile of circulating CD4+ cells in multiple sclerosis | Scientific Reports
PDF) The management and outcomes of fingolimod first dose cardiac monitoring in UK patients with relapsing-remitting multiple sclerosis
Fingolimod-induced atrioventricular conduction defects in a young lady with multiple sclerosis – insights into possible drug mechanism | SpringerLink
A Swiss real world best practice experience in three different clinical settings of the 6 hour fingolimod first dose observation procedure – topic of research paper in Clinical medicine. Download scholarly article
Analysis of cardiac monitoring and safety data in patients initiating fingolimod treatment in the home or in clinic | BMC Neurology | Full Text
Immune cell subset profiling in multiple sclerosis after fingolimod initiation and continued treatment: The FLUENT study - Yang Mao-Draayer, Jeffrey A Cohen, Amit Bar-Or, May H Han, Barry Singer, Ian M Williams,
Addressing the Disease Course - ppt download
Changes in heart rate after the first dose of fingolimod. The time... | Download Scientific Diagram
Patient disposition after first dose of fingolimod administration. | Download Scientific Diagram
Fingolimod for multiple sclerosis. | Semantic Scholar
Recommended patient management plan for treatment with fingolimod. | Download Scientific Diagram
IJMS | Free Full-Text | The First Dose of Fingolimod Affects Circulating Extracellular Vesicles in Multiple Sclerosis Patients
Gilenya Education for First Dose Observation Visit
Risk Mitigation Plan - Educational Material for HCPs v3
Analysis of cardiac monitoring and safety data in patients initiating fingolimod treatment in the home or in clinic | BMC Neurology | Full Text
The safety and efficacy of fingolimod: Real-world data from a long-term, non-interventional study on the treatment of RRMS patients spanning up to 5 years from Hungary | PLOS ONE
IJMS | Free Full-Text | The First Dose of Fingolimod Affects Circulating Extracellular Vesicles in Multiple Sclerosis Patients
Mean heart rate immediately before Fingolimod-initiation and during 8... | Download Scientific Diagram
Fingolimod for Multiple Sclerosis | NEJM
The safety and efficacy of fingolimod: Real-world data from a long-term, non-interventional study on the treatment of RRMS patients spanning up to 5 years from Hungary | PLOS ONE
Fingolimod (Gilenya) First Dose Monitoring The following orders will automatically be enacted unless a specific order is written
